113 related articles for article (PubMed ID: 22297231)
21. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
[TBL] [Abstract][Full Text] [Related]
22. Electron transfer by human wild-type and A287P mutant P450 oxidoreductase assessed by transient kinetics: functional basis of P450 oxidoreductase deficiency.
Jin Y; Chen M; Penning TM; Miller WL
Biochem J; 2015 May; 468(1):25-31. PubMed ID: 25728647
[TBL] [Abstract][Full Text] [Related]
23. Purification and enzymatic properties of a recombinant fusion protein expressed in Escherichia coli containing the domains of bovine P450 17A and rat NADPH-P450 reductase.
Shet MS; Fisher CW; Arlotto MP; Shackleton CH; Holmans PL; Martin-Wixtrom CA; Saeki Y; Estabrook RW
Arch Biochem Biophys; 1994 Jun; 311(2):402-17. PubMed ID: 8203904
[TBL] [Abstract][Full Text] [Related]
24. Purification, cDNA cloning and functional expression of NADPH-cytochrome P450 reductase from Centaurium erythraea cell cultures.
Schwarz H; Liu B; Peters S; Barillas W; Beerhues L
Plant Biol (Stuttg); 2009 May; 11(3):300-6. PubMed ID: 19470102
[TBL] [Abstract][Full Text] [Related]
25. Engineering of a functional human NADH-dependent cytochrome P450 system.
Döhr O; Paine MJ; Friedberg T; Roberts GC; Wolf CR
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):81-6. PubMed ID: 11136248
[TBL] [Abstract][Full Text] [Related]
26. Characterization of two NADPH: cytochrome P450 reductases from cotton (Gossypium hirsutum).
Yang CQ; Lu S; Mao YB; Wang LJ; Chen XY
Phytochemistry; 2010 Jan; 71(1):27-35. PubMed ID: 19883924
[TBL] [Abstract][Full Text] [Related]
27. Optimization of yeast-expressed human liver cytochrome P450 3A4 catalytic activities by coexpressing NADPH-cytochrome P450 reductase and cytochrome b5.
Peyronneau MA; Renaud JP; Truan G; Urban P; Pompon D; Mansuy D
Eur J Biochem; 1992 Jul; 207(1):109-16. PubMed ID: 1628642
[TBL] [Abstract][Full Text] [Related]
28. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
[TBL] [Abstract][Full Text] [Related]
29. The effects of cytochrome b5, NADPH-P450 reductase, and lipid on the rate of 6 beta-hydroxylation of testosterone as catalyzed by a human P450 3A4 fusion protein.
Shet MS; Faulkner KM; Holmans PL; Fisher CW; Estabrook RW
Arch Biochem Biophys; 1995 Apr; 318(2):314-21. PubMed ID: 7733659
[TBL] [Abstract][Full Text] [Related]
30. Characterization of superoxide dismutase-insensitive cytochrome c reductase activity in HL-60 cytosol as NADPH-cytochrome P450 reductase.
Nisimoto Y; Otsuka-Murakami H; Iwata S; Isogai Y; Iizuka T
Arch Biochem Biophys; 1993 May; 302(2):315-21. PubMed ID: 8489236
[TBL] [Abstract][Full Text] [Related]
31. Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b(5) enzymes.
Shimada T; Mernaugh RL; Guengerich FP
Arch Biochem Biophys; 2005 Mar; 435(1):207-16. PubMed ID: 15680923
[TBL] [Abstract][Full Text] [Related]
32. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
[TBL] [Abstract][Full Text] [Related]
33. High-yield expression of a catalytically active membrane-bound protein: human P450 oxidoreductase.
Sandee D; Miller WL
Endocrinology; 2011 Jul; 152(7):2904-8. PubMed ID: 21586563
[TBL] [Abstract][Full Text] [Related]
34. Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains.
Smith GC; Tew DG; Wolf CR
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8710-4. PubMed ID: 8078947
[TBL] [Abstract][Full Text] [Related]
35. Biochemical characteristics of purified beef liver NADPH-cytochrome P450 reductase.
Arinç E; Celik H
J Biochem Mol Toxicol; 2002; 16(6):286-97. PubMed ID: 12481304
[TBL] [Abstract][Full Text] [Related]
36. Kinetic analysis of cytochrome P450 reductase from Artemisia annua reveals accelerated rates of NADH-dependent flavin reduction.
Simtchouk S; Eng JL; Meints CE; Makins C; Wolthers KR
FEBS J; 2013 Dec; 280(24):6627-42. PubMed ID: 24299267
[TBL] [Abstract][Full Text] [Related]
37. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
38. Aromatic substitution of the FAD-shielding tryptophan reveals its differential role in regulating electron flux in methionine synthase reductase and cytochrome P450 reductase.
Meints CE; Simtchouk S; Wolthers KR
FEBS J; 2013 Mar; 280(6):1460-74. PubMed ID: 23332101
[TBL] [Abstract][Full Text] [Related]
39. In vitro characterization of CYP102G4 from Streptomyces cattleya: A self-sufficient P450 naturally producing indigo.
Kim J; Lee PG; Jung EO; Kim BG
Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):60-67. PubMed ID: 28821467
[TBL] [Abstract][Full Text] [Related]
40. Purification and immunochemical characteristics of NADPH-cytochrome P-450 oxidoreductase from tobacco cultured cells.
Imaishi H; Yamada T; Ohkawa H
Biochim Biophys Acta; 1995 Jan; 1246(1):53-60. PubMed ID: 7811731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
